During the past decade, Nyack Hospital conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 7 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Nyack Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 8 trials, followed by "Alliance for Clinical Trials in Oncology" with 4 trials sponsored, "Abbott" with 2 trials sponsored, "SWOG Cancer Research Network" with 2 trials sponsored and "Bavarian Nordic" with 2 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Nyack Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 7 trials as a collaborator, "SWOG Cancer Research Network" with 4 trials as a collaborator, "Cancer and Leukemia Group B" with 3 trials as a collaborator, "NCIC Clinical Trials Group" with 3 trials as a collaborator and "Eastern Cooperative Oncology Group" with 2 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Nyack Hospital" are "Breast Ductal Carcinoma In Situ" (2 trials), "Prostate Cancer" (2 trials), "Adenocarcinoma of the Colon" (1 trials), "Breast Adenocarcinoma" (1 trials) and "Breast Cancer" (1 trials). Many other conditions were trialed in "Nyack Hospital" in a lesser frequency.

Most popular intervention types in "Nyack Hospital" are "Drug" (16 trials), "Other" (14 trials), "Biological" (7 trials), "Radiation" (3 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (8 trials), "Quality-of-Life Assessment" (7 trials), "Questionnaire Administration" (5 trials), "Bevacizumab" (4 trials) and "Placebo" (4 trials). Other intervention names were less common.

The vast majority of trials in "Nyack Hospital" are 10 trials for "All" genders, 5 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Nyack Hospital". undefined are not yet recruiting, 6 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Nyack Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Nyack Hospital, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Nyack Hospital has several departments that took part in Clinical trials: "Hematology-Oncology Associates of Rockland" - 5 trials, "Union State Bank Cancer Center at Nyack Hospital" - 4 trials